FI55843B - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9 10-dihydro-9- eller -10-hydroxi-imino-4-(1-alkyl-4-piperidyliden-4h-benso(4 5)cyklohepta(1 2-b)tiofenderivat och deras syraadditionssalter - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9 10-dihydro-9- eller -10-hydroxi-imino-4-(1-alkyl-4-piperidyliden-4h-benso(4 5)cyklohepta(1 2-b)tiofenderivat och deras syraadditionssalter

Info

Publication number
FI55843B
FI55843B FI110/73A FI11073A FI55843B FI 55843 B FI55843 B FI 55843B FI 110/73 A FI110/73 A FI 110/73A FI 11073 A FI11073 A FI 11073A FI 55843 B FI55843 B FI 55843B
Authority
FI
Finland
Prior art keywords
piperidyliden
syraadditionssalter
eller
cyclohepta
ber
Prior art date
Application number
FI110/73A
Other languages
English (en)
Other versions
FI55843C (fi
Inventor
Jean-Pierre Bourquin
Gustav Schwarb
Erwin Waldvogel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH98872A external-priority patent/CH565172A5/de
Priority claimed from CH99072A external-priority patent/CH569006A5/de
Priority claimed from CH99272A external-priority patent/CH562244A5/de
Priority claimed from CH98672A external-priority patent/CH569012A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to FI790145A priority Critical patent/FI59591C/fi
Application granted granted Critical
Publication of FI55843B publication Critical patent/FI55843B/fi
Publication of FI55843C publication Critical patent/FI55843C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI110/73A 1972-01-24 1973-01-16 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9,10-dihydro-9- eller -10-hydroxi-imino-4-(1-alkyl-4-piperidyliden)-4h-benso(4,5)cyklohepta(1,2-b)tiofenderivat och deras syraadditionssalter FI55843C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI790145A FI59591C (fi) 1972-01-24 1979-01-17 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4h-benso(4,5)syklohepta(1,2-b)tiofen-derivat

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH98872A CH565172A5 (en) 1972-01-24 1972-01-24 4-piperidylidene benzocycloheptathiophenes - - antihistamines and serotonin and acetyl choline inhibitors
CH99072A CH569006A5 (en) 1972-01-24 1972-01-24 4-piperidylidene benzocycloheptathiophenes - - antihistamines and serotonin and acetyl choline inhibitors
CH99272A CH562244A5 (en) 1972-01-24 1972-01-24 4-piperidylidene benzocycloheptathiophenes - - antihistamines and serotonin and acetyl choline inhibitors
CH98672A CH569012A5 (en) 1972-01-24 1972-01-24 4-piperidylidene benzocycloheptathiophenes - - antihistamines and serotonin and acetyl choline inhibitors

Publications (2)

Publication Number Publication Date
FI55843B true FI55843B (fi) 1979-06-29
FI55843C FI55843C (fi) 1979-10-10

Family

ID=27428052

Family Applications (1)

Application Number Title Priority Date Filing Date
FI110/73A FI55843C (fi) 1972-01-24 1973-01-16 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9,10-dihydro-9- eller -10-hydroxi-imino-4-(1-alkyl-4-piperidyliden)-4h-benso(4,5)cyklohepta(1,2-b)tiofenderivat och deras syraadditionssalter

Country Status (14)

Country Link
US (1) US3862156A (fi)
JP (1) JPS5760351B2 (fi)
BE (1) BE794377A (fi)
CY (1) CY992A (fi)
DD (1) DD102701A5 (fi)
DE (1) DE2302944C2 (fi)
FI (1) FI55843C (fi)
FR (1) FR2183663B2 (fi)
GB (1) GB1415591A (fi)
HK (1) HK11279A (fi)
HU (1) HU165130B (fi)
MY (1) MY7900114A (fi)
NL (1) NL7300796A (fi)
SE (1) SE383347B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI761607A (fi) * 1975-06-16 1976-12-17 Sandoz Ag
GB1570500A (en) * 1976-01-02 1980-07-02 Sandoz Ltd Anti-9,10-dihydro-4-(1-methyl-4-piperidylidene)-4h-benzo(4,5) cyclohepta (1,2-b)thiophen-10(9h)-one oxime
US4132796A (en) * 1977-12-01 1979-01-02 Merck & Co., Inc. Antipsychotic 3-trifluoromethylsulfinyl analogs of cyproheptadine
US4356184A (en) * 1980-06-04 1982-10-26 G. D. Searle & Co. Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4355036A (en) * 1980-06-19 1982-10-19 Schering Corporation Tricyclic-substituted piperidine antihistamines
PT1218007E (pt) * 1999-09-13 2011-10-27 Bridge Pharma Inc Isómeros opticamente activos de cetotifeno e metabolitos terapeuticamente activos dos mesmos
DK2243778T3 (en) 2008-01-30 2014-11-17 Nippon Zoki Pharmaceutical Co piperidine
US9296731B2 (en) * 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
CN104031035B (zh) * 2014-06-26 2017-08-25 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬混晶及其制备方法
CN104045633B (zh) * 2014-06-26 2017-07-21 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬晶型a及其制备方法
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297097A (fi) * 1962-08-31
US3491103A (en) * 1963-12-19 1970-01-20 Sandoz Ag Certain 4h-benzo(4,5)cyclohepta-(1,2-b) thiophenes
US3466291A (en) * 1966-02-16 1969-09-09 Sandoz Ag 4(2-dialkylaminoethoxy or 2-piperidinoethoxy) - 9,10 - dihydro benzo(4,5)cyclohepta(1,2-b)thiophene derivatives
CH504466A (de) * 1969-02-07 1971-03-15 Sandoz Ag Verfahren zur Herstellung von 4-(1-Methyl-4-piperidyliden-N-oxid)- -9,10-dihydro-4H-benzo(4,5)cycloheptal(1,2-b)thiophen
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene

Also Published As

Publication number Publication date
DE2302944A1 (de) 1973-08-02
JPS4885575A (fi) 1973-11-13
US3862156A (en) 1975-01-21
FR2183663A2 (fi) 1973-12-21
BE794377A (fr) 1973-07-23
HK11279A (en) 1979-03-16
FI55843C (fi) 1979-10-10
SE383347B (sv) 1976-03-08
MY7900114A (en) 1979-12-31
DE2302944C2 (de) 1982-11-25
NL7300796A (fi) 1973-07-26
CY992A (en) 1979-08-02
HU165130B (fi) 1974-06-28
GB1415591A (en) 1975-11-26
DD102701A5 (fi) 1973-12-20
FR2183663B2 (fi) 1976-07-02
JPS5760351B2 (fi) 1982-12-18

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
FI56839B (fi) Foerfarande foer framstaellning av nya antibakteriella penicillinderivat
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE382060B (sv) Forfarande for framstellning av nya substituerade piperidinoalkanonoximderivat
SE384853B (sv) Forfarande for framstellning av nya aminer
FI55843B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9 10-dihydro-9- eller -10-hydroxi-imino-4-(1-alkyl-4-piperidyliden-4h-benso(4 5)cyklohepta(1 2-b)tiofenderivat och deras syraadditionssalter
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
SE405851B (sv) Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan
FI55998B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-alkylamino-dihydropyridiner
SE382980B (sv) Forfarande for framstellning av nya derivat av hexahydrofenantridin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE396385B (sv) Forfarande for framstellning av n-benshydryl-n'-p-hydroxibensyl-piperaziner
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE385906B (sv) Forfarande for framstellning av kardenolid-3-(2'-desoxi-glykosider)
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
SE387121B (sv) Forfarande for framstellning av nya laktamer